Cell Therapy Training Course

The Cell Therapy Training Course (CTTC) is an application-based, ISCT-ASTCT sponsored full-tuition scholarship program designed by Global CGT experts to train and develop future CGT leaders. This five-day, in-person course is hosted once every two years at one of the CGT Centers of Excellence worldwide.

This course combines lectures, discussions, mentoring, and networking sessions led by the global elite CGT experts to teach scholars the latest knowledge on pre-clinical development, IND development, study-design, cell manufacturing, QA, regulatory affairs, funding, and commercialization. The multi-facet training approach allows scholars to present and refine their projects by applying the learnings from the sessions and mentors.

COURSE TOPICS

Clinical Trial Design & Conduct
Pre-Clinical Development
IND Development
Manufacturing Best Practices
Release Testing Procedures
Quality Systems & Regulatory
Correlatives Studies
Team Science & Research Ethics

INTERESTED IN SUPPORTING TRAINING AND EDUCATION IN THE SECTOR?

Become a sponsor of the Cell Therapy Training Course and help provide full tuition scholarships for the next generation of clinical translational experts in cell and gene therapy.

Full Application Instructions & Criteria

UPCOMING COURSE DATES

Oct 23 – 27, 2023, in-person at Penn Medicine, UPenn, USA
(Application is now closed)

DESIGNED FOR:

Fellow-in-Training or Junior Faculty members working in the BMT and CGT fields.

STRUCTURE:

5 days in-person onsite at Penn Medicine, UPenn, USA

ELIGIBILITY REQUIREMENTS:

Applicant must be an active ISCT or ASTCT member.
Applicants must be a Fellow-in-Training or have a Junior Faculty (two years or less teaching in the BMT and Cellular Therapy field) position.
Previously unselected applicants are eligible and encouraged to apply for the current course.

Applications for the 2023 training course are now closed.

Congratulations to the 2023 ISCT-ASTCT Selected Scholars.

See you in Philadelphia!

The ISCT-ASTCT Cell Therapy Training Course is made possible
with the help of our generous Sponsors

ISCT Co-Chair
Bruce Levine, PhD
Barbara and Edward Netter Professor
University of Pennsylvania
Philadelphia, PA, USA

ASTCT Co-Chair
Marcela Maus, MD, PhD

Director, Cellular Immunotherapy Program
Massachusetts General Hospital

Associate Professor of Medicine
Harvard Medical School
Boston, MA, USA

Andrew Fesnak, MD
Assistant Professor of Clinical Pathology and Laboratory Medicine
Perelman School of Medicine
Director, Cell Manufacturing and Development, CVPF
University of Pennsylvania
Philadelphia, PA, USA

Emily Hopewell, PhD
Assistant Professor
Director Cell and Gene Therapy Manufacturing
Indiana University
Indianapolis, IN, USA

Olalekan Oluwole, MBBS, MPH
Assistant Professor of Medicine Hematology/ Oncology
Vanderbilt University
Nashville, TN, USA

Nirali Shah, MD
NIH Distinguished Scholar
Head of the Hematological Malignancies Section
Pediatric Oncology Branch
National Cancer Institute
Bethesda, MD, USA

Sponsorship Opportunities

Be a part of a legacy training the next generation of cell and gene therapy leaders

Why Support the Cell Therapy Training Course?

Showcase your organization as a solution provider in the CGT product development pipeline.
Network and create lasting relationships with current and future leaders in CGT.
Increase visibility and maximize brand awareness with a relevant and targeted audience.
Demonstrate Corporate Social Responsibility by participating in a critical program that addresses the workforce development crisis.

For more information on sponsorship opportunities, contact Raymond Lam at Raymond@isctglobal.org.

VIEW SPONSORSHIP OPPORTUNITIES

Featured Past Scholars - Where Are They Now?

2017 Scholar
Daniel Dever, PhD
Co-Founder & Head of Discovery Research,
Graphite Bio,
United States

“The CTTC course offered a mountain top overview of how to translate discoveries in the laboratories to commercialized cell and gene therapy personalized drug products. Clearly, it takes a village with high-level communication to synchronize and move forward translational products. The CTTC course described every facet of this" village" and how to streamline it. They covered everything from cell manufacturing to clinical trial design to regulatory affairs and to even the logistics of delivering the drug product to the hospital for infusion. In particular, my favorite aspect of the course was listening to world cell and gene therapy experts (with greater than 75 years of experience combined), like Bruce Levine, David DiGiusto and Stanley Riddell, describe their trials and tribulations over many years of hard work and dedication with the ultimate focus of developing a new drug to benefit patients with unmet medical needs. This type of knowledge is highly motivating and more importantly, is invaluable for me and the next generation of cell and gene therapy leaders. I highly recommend this course for medical professionals who are interested in a career of cell and gene therapy!”

2017 Scholar

Anton Terwisscha van Scheltinga, PhD
Director, QA Operations,
Bristol Myers Squibb,
Netherlands

2015 Scholar
Mireya Paulina Velasquez, MD
PI of Velasquez Lab,
St. Jude Children's Research Hospital,
United States

2017 Scholar
Zlatibor Velickovic, PhD
Facility Director, Cell and Tissue Therapies WA,
Royal Perth Hospital,
Australia